Table 3

Univariate logistic regression analysis of predictors of poor outcome (n=162)

PredictorUnadjusted OR95% CIp Value
Clinical characteristic
 Age (years)1.020.95 to 1.070.52
 Parity (number)0.890.65 to 1.130.38
 BMI (kg/cm2)0.950.89 to 1.020.17
 Systolic blood pressure (mm Hg)0.970.95 to 0.990.02
 Heart rate (beats/min)1.010.99 to 1.030.16
 NYHA functional class1.430.85 to 2.430.18
Medication
 Carvedilol (yes, no)0.670.31 to 1.450.31
 ACE inhibitors (yes, no)0.710.38 to 1.340.29
 Furosemide (yes, no)0.810.24 to 2.780.74
 Digoxin (yes, no)1.310.68 to 2.520.42
Echocardiography
 LVEDD (mm)1.051.00 to 1.110.052
 LVESD (mm)1.071.02 to 1.120.009
 Ejection fraction (%)0.950.91 to 0.990.019
 E/A2.091.29 to 3.390.003
 Deceleration time (ms)0.990.99 to 1.010.09
 LV thrombus0.970.37 to 2.530.95
Laboratory
 Haemoglobin (g/dl)0.860.12 to 1.050.15
 Creatinine (mmol/l)1.010.99 to 1.030.35
 Urea (mmol/l)1.090.95 to 1.250.22
 Total protein (g/l)0.990.96 to 1.020.37
 Albumin (g/l)0.990.96 to 1.020.35
 Total bilirubin (μmol/l)1.010.99 to 1.030.29
 Direct bilirubin (μmol/l)1.010.99 to 1.040.37
 Indirect bilirubin (μmol/l)1.030.99 to 1.080.30
 Alkaline phosphatase (U/l)0.990.99 to 1.000.28
 AST (U/l)1.011.00 to 1.020.033
 ALT (U/l)1.011.00 to 1.020.03
 GGT (U/l)1.000.99 to 1.010.73
 Total cholesterol (mmol/l)0.530.36 to 0.770.001
  • Stepwise multiple logistic regression analysis revealed that, after adjustment for variables including age, systolic blood pressure, medications, LVEF and NYHA functional class, increased LVESD, lower BMI and lower total cholesterol at baseline were independent predictors of the prespecified poor outcome (adjusted OR 1.09, 95% CI 1.04 to 1.15, p=0.001; OR 0.89, 95% CI 0.83 to 0.96, p=0.004; and OR 0.50, 95% CI 0.34 to 0.73, p=0.0004, respectively).

  • ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; GGT, γ-glutamyl transpeptidase; LV, left ventricular; LVEDD, LV end diastolic diameter; LVESD, LV end systolic diameter; NYHA, New York Heart Association.